BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 37146750)

  • 1. Immune Infiltration in Tumor and Adjacent Non-Neoplastic Regions Codetermines Patient Clinical Outcomes in Early-Stage Lung Cancer.
    Cheng C; Nguyen TT; Tang M; Wang X; Jiang C; Liu Y; Gorlov I; Gorlova O; Iafrate J; Lanuti M; Christiani DC; Amos CI
    J Thorac Oncol; 2023 Sep; 18(9):1184-1198. PubMed ID: 37146750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity in the immune microenvironment of bone metastasis in driver-positive non-small cell lung cancer.
    Yang XR; Pi C; Zhang YC; Chen ZH; Zhang XC; Zhu DQ; Yang LL; Yin JC; Deng JY; Yang MY; Luo WC; Wu YL; Zhou Q
    Mol Carcinog; 2023 Jul; 62(7):1001-1008. PubMed ID: 37067398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereotactic Body Radiotherapy Is Effective in Modifying the Tumor Genome and Tumor Immune Microenvironment in Non-Small Cell Lung Cancer or Lung Metastatic Carcinoma.
    Zhou P; Chen D; Zhu B; Chen W; Xie Q; Wang Y; Tan Q; Yuan B; Zuo X; Huang C; Zhu H; Li G
    Front Immunol; 2020; 11():594212. PubMed ID: 33552051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the molecular and immune-landscape of lung cancer associated with cystic airspaces.
    Zheng X; Qiu L; Huang Y; Cheng R; Huang S; Xu K; Cai W; Deng Y; Wang W; Zhong X; Cui F; Hao Z; Liu J
    Mol Immunol; 2024 Apr; 168():75-88. PubMed ID: 38430689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and Validation of a Tumor Microenvironment-Related Gene Signature for Prognostic Prediction in Advanced-Stage Non-Small-Cell Lung Cancer.
    Zhang X; Shi X; Zhao H; Jia X; Yang Y
    Biomed Res Int; 2021; 2021():8864436. PubMed ID: 33860055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unique Immune Gene Expression Patterns in Bronchoalveolar Lavage and Tumor Adjacent Non-Neoplastic Lung Tissue in Non-Small Cell Lung Cancer.
    Kuo CS; Liu CY; Pavlidis S; Lo YL; Wang YW; Chen CH; Ko HW; Chung FT; Lin TY; Wang TY; Lee KY; Guo YK; Wang TH; Yang CT
    Front Immunol; 2018; 9():232. PubMed ID: 29483918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ITGAL expression in non-small-cell lung cancer tissue and its association with immune infiltrates.
    Zhang R; Zhu G; Li Z; Meng Z; Huang H; Ding C; Wang Y; Chen C; Li Y; Liu H; Chen J
    Front Immunol; 2024; 15():1382231. PubMed ID: 38646528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non-Small Cell Lung Cancer.
    Li B; Cui Y; Diehn M; Li R
    JAMA Oncol; 2017 Nov; 3(11):1529-1537. PubMed ID: 28687838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppressed immune microenvironment and repertoire in brain metastases from patients with resected non-small-cell lung cancer.
    Kudo Y; Haymaker C; Zhang J; Reuben A; Duose DY; Fujimoto J; Roy-Chowdhuri S; Solis Soto LM; Dejima H; Parra ER; Mino B; Abraham R; Ikeda N; Vaporcyan A; Gibbons D; Zhang J; Lang FF; Luthra R; Lee JJ; Moran C; Huse JT; Kadara H; Wistuba II
    Ann Oncol; 2019 Sep; 30(9):1521-1530. PubMed ID: 31282941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Correlation between Immune Microenvironment Features and EGFR Mutation Status 
in Lung Adenocarcinoma].
    Zhu H; Chen P; Dong G; Meng F; Xia Z; You J; Kong X; Wu J; Yuan F; Yu X; Sun Q; Ji J; Wang S; Liu T; Xu L
    Zhongguo Fei Ai Za Zhi; 2023 Mar; 26(3):204-216. PubMed ID: 37035883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-Cell Receptor Profiling and Prognosis After Stereotactic Body Radiation Therapy For Stage I Non-Small-Cell Lung Cancer.
    Wu L; Zhu J; Rudqvist NP; Welsh J; Lee P; Liao Z; Xu T; Jiang M; Zhu X; Pan X; Li P; Zhou Z; He X; Yin R; Feng J
    Front Immunol; 2021; 12():719285. PubMed ID: 34733273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multidimensional profiling depicts infiltrating immune cell heterogeneity in the tumor microenvironment of stage IA non-small cell lung cancer.
    Duan J; Lv G; Zhu N; Chen X; Shao Y; Liu Y; Zhao W; Shi Y
    Thorac Cancer; 2022 Apr; 13(7):947-955. PubMed ID: 35150094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Value of the Tumor Immune Microenvironment for Early-stage, Non-Small Cell Lung Cancer.
    Tuminello S; Petralia F; Veluswamy R; Wang P; Flores R; Taioli E
    Am J Clin Oncol; 2021 Jul; 44(7):350-355. PubMed ID: 34008498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of T cell receptor repertoire in penile cancer.
    Zhang J; Wang Y; Huang Y; Tan X; Xu J; Yan Q; Tan J; Zhang Y; Zhang J; Ma Q; Zhu H; Ye J; Zhu Z; Lan W
    Cancer Immunol Immunother; 2024 Jan; 73(2):24. PubMed ID: 38280010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spatial heterogeneity of T cell repertoire across NSCLC tumors, tumor edges, adjacent and distant lung tissues.
    Hu Q; Frank ML; Gao Y; Ji L; Peng M; Chen C; Wang B; Hu Y; Wu Z; Li J; Shu L; He Q; Zhang Y; Xia X; Zhang J; Yi X; Reuben A; Yu F
    Oncoimmunology; 2023; 12(1):2233399. PubMed ID: 37876834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immune microenvironment in non-small cell lung cancer is predictive of prognosis after surgery.
    Öjlert ÅK; Halvorsen AR; Nebdal D; Lund-Iversen M; Solberg S; Brustugun OT; Lingjaerde OC; Helland Å
    Mol Oncol; 2019 May; 13(5):1166-1179. PubMed ID: 30854794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the tumor-infiltrating immune repertoire in muscle invasive bladder cancer.
    Benítez R; Yu K; Sirota M; Malats N; Pineda S
    Front Immunol; 2023; 14():986598. PubMed ID: 36817478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic Analysis of the Prognostic Significance and Roles of the Integrin Alpha Family in Non-Small Cell Lung Cancers.
    Huang Y; Guo DM; Bu S; Xu W; Cai QC; Xu J; Jiang YQ; Teng F
    Adv Ther; 2023 May; 40(5):2186-2204. PubMed ID: 36892810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APE1 may influence CD4+ naïve T cells on recurrence free survival in early stage NSCLC.
    Li Y; Zhao X; Xiao H; Yang B; Liu J; Rao W; Dai X; Li M; Dai N; Yang Y; Wang D
    BMC Cancer; 2021 Mar; 21(1):233. PubMed ID: 33676448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High gene expression of estrogen and progesterone receptors is associated with decreased t cell infiltration in patients with NSCLC.
    Oh MS; Anker JF; Chae YK
    Cancer Treat Res Commun; 2021; 27():100317. PubMed ID: 33711637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.